Related posts

Tariff war pressures markets for the weekPositive Friday ends choppy week and down monthTSX flat as tech pressures markets
Investor Insights

This summary was created by AI, based on 13 opinions in the last 12 months.

Walgreens Boots Alliance (WBA) is facing a challenging period, with mixed sentiments from various experts ahead of its earnings report. Some analysts view the recent acquisition of Boots as questionable and believe that the company may regret this large investment. The company's turnaround efforts seem to make some headway with one expert noting a potentially positive quarter, but many remain cautious due to extensive debt and ongoing struggles within the retail pharmacy sector. Concerns about poor execution and the need for strategic shifts, such as AI investments and cost-cutting, have surfaced, while others suggest divesting in favor of competitors like CVS. Overall, while there might be some optimism in the short-term trend, significant risks loom, and experts advise caution regarding WBA's future performance.

Consensus
Avoid
Valuation
Overvalued
COMMENT

They report Tuesday. He likes their deal in which they go private. Let's see if things have gotten better or if there is buyer's remorse.

SELL

They entered a great deal (Walgreens to be taken private by Sycamore in $10 billion). If you own shares, sell and buy Costco.

RISKY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

It was a good quarter. But it is important to note that one quarter does not make a trend, and there is still lots of work to be done here. It is still in turnaround mode. It still has a massive amount of debt. It is cheap, though, and the quarter might see shorts start to cover a bit. So the trend will likely be 'up' and the worst 'could' be over here. But there remains plenty of risk and we would prefer to see another quarter or two of continued improvement, and even pay more once the turn is indeed fully established and on a firm foothold. Much could still go wrong here. 
Unlock Premium - Try 5i Free

DON'T BUY

It reports Friday.  It needs to do something to help its woes. He suspect the CEO has buyers lined up for parts of the company. Don't bet against the CEO, but don't bet on WBA.

SELL

Many headwinds, too big to overcome. Sell, take the loss.

DON'T BUY

He bought CVS instead. WBA did a big purchase of Boots which they may be regretting. WBA really operates pharmacies, plus a medical business. He prefers CVS for Aetna, their insurance business, pharmacy benefits and a medical business.

DON'T BUY

Avoid, because of poor execution and being in a poor sector. There will be a tax on online delivery services. Too many problems.

COMMENT

It will go down only 9 more points. The new CEO needs to invest AI, cut overhead and increase profit. 

DON'T BUY

Problems. Avoid. Called "value", but continues to move south. Technically, 200-day MA is going lower and stock price is below that. 5x forward PE, but earnings growth is negative.

DON'T BUY

The alliance had all this promise, and just hasn't been able to deliver. He's not brave or smart enough to pick the bottom on a stock like this. He owns Loblaw and, with it, Shopper's Drug Mart.

DON'T BUY

Beware of companies closing stores and calling that successfully. Closing stores is never good. This whole space has been challenged. He had a poor experience holding the peer, CVS. WBA was just kicked out of an index.

DON'T BUY

One of the things he looks at is sustainability of dividends. Are you paying your dividends through free cashflow? Cut dividend. Struggled ever since acquiring Boots in the UK a decade ago, which has crippled the company.

DON'T BUY

Stock's been completely annihilated. It's only in the drugstore chain business, which has been really tough.

WATCH
One of the five worst performers in Q1

Down 17% in Q1, plus another 10% today. The CEO though could turn things around in a year. No hurry to buy this one.

DON'T BUY

Wait another quarter to see what the CEO will do. Don't jump the gun. It's a troubled company.

Showing 1 to 15 of 261 entries

Walgreen Boots Alliance(WBA-Q) Rating

Ranking : 3 out of 5

Star iconStar iconStar iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 10

Total Signals / Votes : 11

Stockchase rating for Walgreen Boots Alliance is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Walgreen Boots Alliance(WBA-Q) Frequently Asked Questions

What is Walgreen Boots Alliance stock symbol?

Walgreen Boots Alliance is a American stock, trading under the symbol WBA-Q on the NASDAQ (WBA). It is usually referred to as NASDAQ:WBA or WBA-Q

Is Walgreen Boots Alliance a buy or a sell?

In the last year, 11 stock analysts published opinions about WBA-Q. 1 analyst recommended to BUY the stock. 10 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Walgreen Boots Alliance.

Is Walgreen Boots Alliance a good investment or a top pick?

Walgreen Boots Alliance was recommended as a Top Pick by on . Read the latest stock experts ratings for Walgreen Boots Alliance.

Why is Walgreen Boots Alliance stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Walgreen Boots Alliance worth watching?

11 stock analysts on Stockchase covered Walgreen Boots Alliance In the last year. It is a trending stock that is worth watching.

What is Walgreen Boots Alliance stock price?

On 2025-04-15, Walgreen Boots Alliance (WBA-Q) stock closed at a price of $10.86.